Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements
DRUGGIST DISCRIMINATIONS
CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients
Clinical Utility and Economic Impact of CYP2D6 Genotyping - PubMed
The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness
326085
CYP2D6 and CYP2A6 biotransform dietary tyrosol into hydroxytyrosol - PubMed
Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
Potential role of CYP2D6 in the central nervous system
CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients - PubMed
Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis - PubMed
Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis - PubMed
Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers - PubMed
Low frequency of CYP2D6 poor metabolizers among schizophrenia patients - PubMed
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
CYP2D6 copy number distribution in the US population
CYP2D6 polymorphisms and their influence on risperidone treatment
Genetic polymorphism of CYP2D6 in patients with systemic lupus erythematosus and systemic sclerosis - PubMed
Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosis - PubMed
CYP2D6*4 Allele Polymorphism Increases the Risk of Parkinson’s Disease: Evidence from Meta-Analysis
Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics
Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype - PubMed
MPTP to dopamine-sensitive neurons and also add a CYP2D6 inhibitor - Ecosia
Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6: IMPLICATIONS IN PARKINSON DISEASE - ScienceDirect
Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6: IMPLICATIONS IN PARKINSON DISEASE - ScienceDirect
Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6: IMPLICATIONS IN PARKINSON DISEASE - ScienceDirect
pups’ transition - Ecosia